Kits
Urine CrossLaps® (CTX-I) EIA
Kits
Description
The Urine CrossLaps® (CTX-I) EIA is an enzyme immunosorbent assay for quantitative determination of degradation products of C-terminal telopeptides of Type-I collagen in human urine.
The Urine CrossLaps® (CTX-I) EIA assay is intended for in vitro diagnostic use as an indication of human bone resorption and may be used as an aid in:
Monitoring bone resorption changes of:
Anti-resorptive therapies in postmenopausal women:
Hormone Replacement Therapies (HRT) with hormones and hormone-like drugs
Bisphosphonate therapies
Anti-resorptive therapies in individuals diagnosed with osteopenia:
Hormone Replacement Therapies (HRT) with hormones and hormone-like drugs
Bisphosphonate therapies.
Predicting skeletal response (Bone Mineral Density) in postmenopausal women undergoing anti-resorptive therapies:
Hormone Replacement Therapies (HRT) with hormones and hormone-like drugs
Bisphosphonate
The Urine CrossLaps® (CTX-I) EIA assay is intended for in vitro diagnostic use as an indication of human bone resorption and may be used as an aid in:
Monitoring bone resorption changes of:
Anti-resorptive therapies in postmenopausal women:
Hormone Replacement Therapies (HRT) with hormones and hormone-like drugs
Bisphosphonate therapies
Anti-resorptive therapies in individuals diagnosed with osteopenia:
Hormone Replacement Therapies (HRT) with hormones and hormone-like drugs
Bisphosphonate therapies.
Predicting skeletal response (Bone Mineral Density) in postmenopausal women undergoing anti-resorptive therapies:
Hormone Replacement Therapies (HRT) with hormones and hormone-like drugs
Bisphosphonate